Navigation Links
Surgeons at University of California San Diego Perform 1st TRAM Flap Procedure in an International Multi-Center Study Using TIGR® Matrix Surgical Mesh, the World's 1st Long-Term Resorbable Mesh
Date:1/25/2011

SINGAPORE, Jan. 25, 2011 /PRNewswire/ -- Novus Scientific Pte. Ltd, a Singapore company, announced today that Dr. James Chao of the University of California San Diego (UCSD) has operated on his first TRAM Flap patient using TIGR® Matrix Surgical Mesh.

This is part of the international multi-center, randomized trial "Abdominal Wall Closure After Lipectomy, TRAM/DIEP Flap – Comparison of TIGR® Matrix (100% Resorbable) vs Polypropylene (Permanent) Mesh". This ground-breaking study involves UCSD in the U.S. as well as the National University Hospital and Tan Tock Seng Hospitals in Singapore.

"We're pleased to operate on our 1st patient for this study as we certainly see a trend towards bio-absorbable meshes and a move away from permanent meshes in abdominal wall and hernia repairs. TIGR® Matrix potentially gives the body optimal time to grow strong, functional tissue, yet avoids long-term complications associated with permanent meshes. We will be monitoring the patient with great interest during follow up." - James J. Chao, MD FACS, Study Investigator, Professor of Plastic Surgery and Orthopedic Surgery, University of California, San Diego (UCSD) Medical Centre

"We're very pleased to have Professor James Chao of UCSD as a collaborator in this multi-center study as he brings a wealth of experience and expertise to this area. If this study confirms TIGR® Matrix to be significantly better, this will influence our TRAM Flap treatment protocol to use a long-term 100% resorbable mesh rather than a permanent polypropylene mesh in the future. I'm sure surgeons and patients will be delighted to have a 100% synthetic option available that avoids long-term mesh complications."- Associate Professor Thiam Chye Lim, Principal Investigator & Head of Division of Plastic, Reconstructive and Aesthetic Surgery, National University Hospital, Singapore.

"The participation of UCSD in this study is very exciting as it will result in crucial US study data for TIGR® Matrix," said Thomas Engstrom, CEO & President of Novus Scientific. "TIGR® Matrix is designed to be strong when you need it and gone when you don't when delivering the best possible long-term outcome for the patient. It is very satisfying to see the product being adopted so enthusiastically by experts such as Prof. Chao."

About TIGR® Matrix Surgical Mesh

TIGR® Matrix is the World's 1st Long-Term Resorbable Synthetic Mesh. Product R&D and the first patent were initiated in 2004 and it was cleared by the U.S. FDA for use in reinforcement of soft tissues where weakness exists and launched for sale in the United States in 2010. TIGR® Matrix Surgical Mesh is being used successfully for numerous surgical repairs including: inguinal hernia, TRAM/DIEP Flap donor site and ventral hernia. Surgical procedures have been performed in the Far East and Europe as well as in the United States.

About Novus Scientific

Novus Scientific (www.novusscientific.com) is an innovator in the development and commercialization of resorbable synthetic medical devices. Global HQ is in Singapore while European Headquarters and the core R&D function are in Uppsala, Sweden. The company's roots are Swedish as all the founders of Novus Scientific are previous owners / senior managers / members of the soft tissue-engineering project within Uppsala-based, Radi Medical Systems AB (now owned by St. Jude Medical Inc). The U.S. Division, Novus Scientific, Inc. is headquartered near Boston, one of the world's foremost medical research cities. From this hub, Novus Scientific, Inc. will distribute TIGR® Matrix Surgical Mesh throughout the United States, Canada, and Latin America.

TIGR® is a trademark of Novus Scientific Pte. Ltd

CONTACT: Tac-Whei Ong, +65 9179 6661, tacwhei.ong@novusscientific.com; or Jim Archetto, jim.archetto@novusscientific.com, +1-508-769-5902 (U.S. Office)


'/>"/>
SOURCE Novus Scientific Pte. Ltd
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
2. Surgeons Find That Laparoscopic Banding Procedure Helps Overweight Adolescents Lose Weight and Improve Health
3. Surgeons Develop Innovative Life-Saving Treatments to Correct Massive Bleeding in Trauma Patients
4. Got Fat?: Plastic Surgeons Review Fat-Melting and Fat-Grafting Procedures
5. Legacy Good Samaritan Hospital Surgeons Find BSGI Effective in Determining Extent of Breast Cancer in Patients With Known Diagnosis
6. American Heart Association Journal Report: Surgical Residents Perform Heart Surgery as Effectively as Staff Surgeons
7. Vascular Surgeons Agree: Case Rehearsal Improves Outcomes
8. Plastic Surgeons Warn of Malnutrition in Body Contouring Patients
9. Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center
10. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress
11. Cleveland Clinic Surgeons Perform Nations First Near-Total Face Transplant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... , Feb. 11, 2016 Potrero Medical, Inc., the ... to announce the appointment of George M. Rapier, III ... San Antonio, TX , WellMed is one of the ... patients and HMO members in Texas ... 1990 out of his own internal medicine practice, he has ...
(Date:2/11/2016)... -- MiMedx Group, Inc. (NASDAQ: MDXG ), the leading ... birth tissues, human skin and bone, and patent-protected processes ... and therapies, announced today that it will present at ... New York , NY.  Parker H. ... , Chief Financial Officer and Chris Cashman , ...
(Date:2/11/2016)...  AfterPill.com is reporting that this week,s Centers for ... women who are at risk of unintended pregnancy impacts ... raises the risks of unprotected sex in particular.  ... to the Guttmacher Institute, there are 43 million women ... who have sex without the intention of becoming pregnant.  ...
Breaking Medicine Technology:
(Date:2/13/2016)... ... February 13, 2016 , ... In the early or “honeymoon” stage ... to perfection, go out of their way to be romantic, and may exaggerate a ... look at any online dating profile. , A recent study from Queendom.com ...
(Date:2/12/2016)... Opelousas, LA (PRWEB) , ... February 12, 2016 , ... ... of St. Landry and Evangeline Parishes. The purpose of these scholarships is to ... to encourage those individuals to seek employment within these two parishes. , “We ...
(Date:2/12/2016)... ... February 12, 2016 , ... Fixed Dose Combination Drug Development: ... EST, http://www.fdanews.com/fixeddosecombination , Fixed dose combination products are ... attention from all stakeholders in the development of new chemical entities. , However, ...
(Date:2/12/2016)... ... 2016 , ... T.E.N., a technology and information security executive ... Awards 2016. Finalists and winners of the ISE® Awards for both Executive and ... Gala on March 15, 2016 at the Westin Peachtree Plaza, Atlanta. , ...
(Date:2/12/2016)... ... 12, 2016 , ... Fisher House Foundation Chairman and CEO Kenneth Fisher joined ... Support Alliance president Scott Bensing, and Peggy Kearns Director, VA Southern Nevada Healthcare System ... This will be the first Fisher House in Nevada, and will provide free ...
Breaking Medicine News(10 mins):